The Sick Times
  • Sections
    • Arts & Culture
    • Commentary
    • COVID-19
    • Health
    • International
    • Podcast
    • Policy & Advocacy
    • Science
  • About
    • Our team
    • Write for us
    • Transparency & policies
  • Resources
Newsletter
Donate
  • The (sick) kids aren’t alright: Observations from a teacher with Long COVID

    The (sick) kids aren’t alright: Observations from a teacher with Long COVID

    Flynn Lovelace

    We must help students by addressing Long COVID and advocating for clean air in schools. Read more…

Recent articles

  • Why is airborne disease transmission still controversial to doctors?
    Podcast
    Melanie Marich

    Why is airborne disease transmission still controversial to doctors?

  • How to interpret clinical trial results for Long COVID
    Science
    Simon Spichak

    How to interpret clinical trial results for Long COVID

  • Research updates, July 21
    Science
    Miles W. Griffis

    Research updates, July 21

Get the latest Long COVID news and commentary

Sign up for our free newsletter, delivered every Tuesday! Receive our latest stories, research updates, COVID-19 trends, and more.

Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.

Check out our weekly podcast, Still Here

SpotifySpotifyApple PodcastsApple PodcastsPocketCastsPocketCastsiHeartRadioiHeartRadioRSSRSS

Trending

Abandoned by our governments, people with severe ME and Long COVID are supported by severely ill peersAbandoned by our governments, people with severe ME and Long COVID are supported by severely ill peersWhitney Fox
What can professional athletes teach us about Long COVID and rest?What can professional athletes teach us about Long COVID and rest?Melanie Marich
How to interpret clinical trial results for Long COVIDHow to interpret clinical trial results for Long COVIDSimon Spichak
National COVID-19 trends, July 21National COVID-19 trends, July 21Betsy Ladyzhets
FDA approves COVID-19 antiviral Xocova as PEP. But will it be accessible?FDA approves COVID-19 antiviral Xocova as PEP. But will it be accessible?Miles W. Griffis

Policy & Advocacy

Science

  • Novel Coronavirus SARS-CoV-2–Colorized scanning electron
    January 23, 2024

    Research updates, January 23

  • Novel Coronavirus SARS-CoV-2–Transmission electron micrograph
    January 16, 2024

    Research updates, January 16

  • January 9, 2024

    New CDC data identify more than 5,000 Long Covid deaths, but tally is likely a significant undercount

  • January 9, 2024

    What’s happening this week, January 9

  • January 2, 2024

    Q&A: Eric Topol on Long Covid clinical trials, RECOVER funding, what he’s looking forward to in 2024

  • January 2, 2024

    What’s happening this week, January 2

Previous Page
1 … 33 34 35 36 37
Next Page

Covid-19

Health

Commentary

  • A collage of charts from the NIH ME/CFS intramural study showing differences between healthy volunteers and ME/CFS participants. The image includes an emoji giving air quotes and the term "effort preference" in bold black letters.
    September 27, 2024

    Five reasons why the NIH should retract the “effort preference” claims in their intramural ME/CFS paper

  • September 9, 2024

    The first major novel on Long COVID falls for harmful tropes. It doesn’t have to be this way.

  • September 3, 2024

    “Perfect storm” of criminalization: Analyzing mask bans

  • September 3, 2024

    As a doctor, I’m disappointed in my colleagues for ignoring Long COVID. I made a resource to educate them and the public.

Previous Page
1 … 18 19 20 21 22 … 26
Next Page

The Sick Times is an independent news site founded by journalists Betsy Ladyzhets and Miles Griffis. We report on the Long COVID crisis, COVID-19, and infection-associated illnesses.

Contact:
editors@thesicktimes.org

PO Box 331009
Brooklyn, NY 11233

  1. Home
  2. About
  3. Newsletter
  4. Podcast
  5. Transparency & policies
  6. Write for us
  7. Resources
  8. Donate
  • Twitter
  • Instagram
  • YouTube
  • Facebook
  • Bluesky

Sign up for our free newsletter, delivered every Tuesday. Receive our latest stories, research updates, COVID-19 trends, and more.

Processing…
Success! You're on the list 🙂
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.

© 2026 The Sick Times

Loading Comments...